⌘K

Login Start Free

Home/Filings/4/0001209191-21-014478

4//SEC Filing

Chiang Kyle 4

Accession 0001209191-21-014478

CIK 0001664106other

View on SEC.gov Company Profile

Filed

Feb 24, 7:00 PM ET

Accepted

Feb 25, 7:00 PM ET

Size

5.3 KB

Accession

0001209191-21-014478

Insider Transaction Report

Form 4

Period: 2021-02-23

LogicBio Therapeutics, Inc.LOGC

Chief Operating Officer

Transactions

Award
Stock Option (right to buy)
2021-02-23+155,701→ 155,701 total
Exercise: $7.76Exp: 2031-02-23→ Common Stock (155,701 underlying)

Footnotes (1)

[F1]25% vests on 01/01/2022 and the remainder vests in equal monthly installments over the next 36 months.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

LogicBio Therapeutics, Inc.

CIK 0001664106

Entity typeother

Related Parties

1

filerCIK 0001831341

Filing Metadata

Form type: 4
Filed: Feb 24, 7:00 PM ET
Accepted: Feb 25, 7:00 PM ET
Size: 5.3 KB

View on SEC.gov